Evidence map›Paper›PMID 35081365›Full record

ArticleMolecular cell2022

scDART-seq reveals distinct m

Matthew Tegowski, Mathieu N Flamand, Kate D Meyer

Abstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. mNature reviews. Neuroscience · 2026
    Review
  9. Review
  10. Spatially resolved mNature methods · 2026
    Article
  11. Article
  12. mBiomolecules · 2026
    Review
  13. The relevance of mJournal of cancer research and clinical oncology · 2026
    Review
  14. The Role of NMedComm · 2026
    Review
  15. cGAMP suppresses FTO expression to promote mCellular and molecular life sciences : CMLS · 2026
    Article
  16. RNA modifications in cancer and their detection: a review.Japanese journal of clinical oncology · 2026
    Review
  17. Review
  18. Systematic identification of tissue-conserved mbioRxiv : the preprint server for biology · 2026
    Article
  19. RNA mCell biology and toxicology · 2026
    Review
  20. Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Matthew TegowskiDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA.
Mathieu N FlamandDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA.
Kate D MeyerDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, USA; Department of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kate.meyer@duke.edu.

Funding

Center for Multi-Scale Analysis of the Human EpitranscriptomeRM1HG011563 · NHGRI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAMIE R JAFFREY, Kathryn D Meyer · 2021 to 2026
$22.2M
Epitranscriptomic Regulation of Synaptic Responses to Drugs of AbuseDP1DA046584 · NIDA · DUKE UNIVERSITY · PI MEYER, KATHRYN D · 2018 to 2022
$2.4M
Mechanistic Insights into m6A-Mediated Regulation of Brain DevelopmentR01MH118366 · NIMH · DUKE UNIVERSITY · PI MEYER, KATHRYN D · 2019 to 2023
$2.0M
NHGRI NIH HHS RM1 HG011563NIDA NIH HHS DP1 DA046584NIMH NIH HHS R01 MH118366
6 · The paper itself

Abstract

N

Indexed as

Gene Expression ProfilingRNA Processing, Post-TranscriptionalSequence Analysis, RNASingle-Cell AnalysisTranscriptomeAdenosineHEK293 CellsHumansMethylationRNA, MessengerAdenosineN-methyladenosineRNA, Messenger

Identifiers

PMID35081365
PMCPMC8857065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.